Bioactive Organocopper Compound from Pseudomonas aeruginosa Inhibits the Growth of Xanthomonas citri subsp. citri by Admilton G. de Oliveira et al.
ORIGINAL RESEARCH
published: 09 February 2016
doi: 10.3389/fmicb.2016.00113
Edited by:
Márcia Vanusa Da Silva,
Universidade Federal
de Pernambuco, Brazil
Reviewed by:
Anushree Malik,
Indian Institute of Technology, Delhi,
India
Martin Picard,
CNRS UMR7099, France
Bhekumthetho Ncube,
University of KwaZulu-Natal,
South Africa
*Correspondence:
Galdino Andrade
andradeg@uel.br
Specialty section:
This article was submitted to
Antimicrobials, Resistance
and Chemotherapy,
a section of the journal
Frontiers in Microbiology
Received: 07 August 2015
Accepted: 22 January 2016
Published: 09 February 2016
Citation:
de Oliveira AG, Spago FR,
Simionato AS, Navarro MOP,
da Silva CS, Barazetti AR, Cely MVT,
Tischer CA, San Martin JAB, de Jesus
Andrade CGT, Novello CR, Mello JCP
and Andrade G (2016) Bioactive
Organocopper Compound from
Pseudomonas aeruginosa Inhibits
the Growth of Xanthomonas citri
subsp. citri. Front. Microbiol. 7:113.
doi: 10.3389/fmicb.2016.00113
Bioactive Organocopper Compound
from Pseudomonas aeruginosa
Inhibits the Growth of Xanthomonas
citri subsp. citri
Admilton G. de Oliveira1, Flavia R. Spago1, Ane S. Simionato1, Miguel O. P. Navarro1,
Caroline S. da Silva1, André R. Barazetti1, Martha V. T. Cely1, Cesar A. Tischer2,
Juca A. B. San Martin3, Célia G. T. de Jesus Andrade3, Cláudio R. Novello4,
João C. P. Mello4 and Galdino Andrade1*
1 Laboratório de Ecologia Microbiana, Departamento de Microbiologia, Universidade Estadual de Londrina, Londrina, Brazil,
2 Laboratório de Espectroscopia, Departamento de Bioquímica e Biotecnologia, Universidade Estadual de Londrina,
Londrina, Brazil, 3 Laboratório de Microscopia Eletrônica e Microanálise, Departamento de Biologia Geral, Universidade
Estadual de Londrina, Londrina, Brazil, 4 Laboratório de Produtos Fitoterápicos, Departamento de Farmácia e Farmacologia,
Universidade Estadual de Maringá, Maringá, Brazil
Citrus canker is a very destructive disease of citrus species. The challenge is to find
new compounds that show strong antibiotic activity and low toxicity to plants and
the environment. The objectives of the present study were (1) to extract, purify and
evaluate the secondary metabolites with antibiotic activity produced by Pseudomonas
aeruginosa LV strain in vitro against Xanthomonas citri subsp. citri (strain 306), (2)
to determine the potential of semi-purified secondary metabolites in foliar application
to control citrus canker under greenhouse conditions, and (3) to identify antibiotic
activity in orange leaf mesophyll infected with strain 306, by electron microscopy. Two
pure bioactive compounds were isolated, an organocopper antibiotic compound (OAC)
and phenazine-1-carboxamide. Phenazine-1-carboxamide did not show any antibiotic
activity under the experimental conditions used in this study. The OAC showed a high
level of antibiotic activity with a minimum inhibitory concentration of 0.12 g mL−1μ . In
greenhouse tests for control of citrus canker in orange trees, the semi-purified fraction
F3d reduced lesion formation by about 97%. The concentration used was 500 times
lower than that for the recommended commercial copper-based product. Electron
microscopy showed that F3d altered the exopolysaccharide matrix and caused cell lysis
of the pathogen inside the citrus canker lesions. These results suggest that secondary
metabolites produced by inducing P. aeruginosa LV strain have a high potential to be
used as a bioproduct to control citrus canker.
Keywords: Pseudomonas secondary metabolites, citrus canker, purification process, antibiotic activity, bioactive
compounds
INTRODUCTION
Brazil is one of the largest producers of orange juice concentrate in the world (Neves et al., 2010),
earning over US$ 2 billion a year. However, citrus growers have suﬀered increasing losses mainly
due to citrus canker and greening (Huanglongbing), where in the last decade, they were forced
to destroy millions of trees (USDA, 2015). Citrus canker is one of the most destructive diseases
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of many commercial citrus species (Gottwald and Graham,
2000), and it is found in the biggest sweet orange producing
areas, such as São Paulo State, Brazil, and Florida, USA. The
etiological agent is Xanthomonas citri subsp. citri (synonyms
X. axonopodis pv. citri, X. campestris pv. citri, and X. citri
pv. citri), a Gram-negative, rod-shaped pathogenic bacterium
belonging to the class Gammaproteobacteria (Gabriel et al.,
1989; Schaad et al., 2005, 2006), and the genera of this family
can infect over 350 species of plants (Chan and Goodwin,
1999).
Citrus canker causes premature fruit drop, defoliation, and
shoot dieback. The infection begins by X. citri subsp. citri
penetrating through natural openings (stomata) and wounds
(Gottwald et al., 2002). Bacteria spread in orchards by wind-
blown rain, and the colonization of leaf mesophyll increases with
the presence of the citrus leaf miner Phyllocnistis citrella Stainton
(Lepidoptera: Gracillariidae; Chagas et al., 2001). Growers use
integrated management approaches such as cultivating less-
susceptible citrus genotypes produced in X. citri subsp. citri-free
nurseries, control of P. citrella, planting windbreaks as barriers to
hinder the spread of the disease, and spraying synthetic copper
bactericides (Schubert and Sun, 1996; Belasque and Behlau,
2011).
Today, research focuses on disease control in citrus crops in
many ways, using systemic acquired resistance (SAR; Graham
and Leite, 2004; Graham and Myers, 2009; Miller et al.,
2011), obtaining more resistant citrus varieties (Fu et al., 2011;
Yang et al., 2011), bacteriophages (Balogh et al., 2008) and
Pseudomonas secondary metabolites (Góis et al., 2013; Spago
et al., 2014; Murate et al., 2015). The low eﬃciency in controlling
X. citri subsp. citri using commercially available compounds
presents challenges in ﬁnding new techniques and/or products
for control that are non-hazardous to the environment, have
high bactericidal eﬀects and are eﬀective in infested internal
tissues.
The potential of Pseudomonas species to suppress plant
pathogens is well known (Dowling and O’Gara, 1994;
Raaijmakers et al., 1997; Haas and Défago, 2005), and secondary
metabolites produced by Pseudomonas show strong antibiotic
activity, including phenazines, pyrrolnitrin-type antibiotics,
pyo compounds, indole derivatives, peptides, glycolipids, lipids
and aliphatic compounds (Fuller et al., 1971; Leisinger and
Margraﬀ, 1979; Ligon et al., 2000; Raaijmakers et al., 2002,
2006; Haas and Keel, 2003; Paulsen et al., 2005; Gross and
Loper, 2009). Pseudomonas secondary metabolites can be an
alternative source of new compounds for the control of plant
diseases.
Given this background, the aims of our study were: (1)
to extract, purify and evaluate the antimicrobial activity of
secondary metabolites of Pseudomonas aeruginosa LV strain
produced in vitro against X. citri subsp. citri (strain 306. Xcc
306), (2) to determine the potential of semi-puriﬁed secondary
metabolites in foliar application to control citrus canker under
greenhouse conditions, and (3) to identify the biological activity
of semi-puriﬁed secondary metabolites inside the leaf, reducing
the inoculum potential inside the citrus canker lesions by electron
microscopy.
MATERIALS AND METHODS
Chemicals and Media
All chemicals used for extraction and puriﬁcation were of
analytical grade. Silica gel and thin layer chromatography
(TLC) plates were from Macherey–Nagel GmbH & Co. KG.
Microbiological media were from Becton Dickinson and
Company. Chemicals used for antimicrobial and cytotoxicity
assays were purchased from Sigma–Aldrich. All other reagents
were of analytical grade and the other chemicals used were of the
highest purity.
Bacterial Strains
The pathogen X. citri subsp. citri strain 306 (Xcc 306), whose
genome has been sequenced (da Silva et al., 2002), was used
in all experiments. Xcc 306 was stored in 40% glycerol (v/v)
at –20◦C, and the stock culture was renewed every 6 months and
cultivated in nutrient agar (NA) at 28◦C for 48 h. The antagonistic
bacterium used was P. aeruginosa LV strain, which was isolated
from an old citrus canker lesion on leaves of orange plants (Citrus
sinensis cv. Valence), in the city of Astorga, Brazil (Rampazo,
2004). P. aeruginosa was maintained on NA plus copper chloride
(CuCl2) (0.5% peptone, 0.3% meat extract, 0.01% CuCl2·2H2O
and 1.5% agar; pH 6.8) at room temperature (28 ± 2◦C) as
the working culture. Glycerol stocks were also prepared and
stored at –20◦C throughout the study. The bacterial strains were
deposited in the Microbial Culture Collection of the Laboratory
of Microbial Ecology, Londrina State University, Brazil.
Molecular Identification of Antagonistic
Bacterium Strain LV
According to the result of a 16S rDNA partial base sequence
and the API identiﬁcation system, strain LV was closest to
P. aeruginosa, where the 16S rDNA partial base sequence showed
more than 99.9% similarity.
Production and Purification of
Metabolites with Antibiotic Activity
The culture parameters such as medium, pH, inoculum load,
stirring, temperature, and culture age were standardized to
optimize the growth of LV strains, and the production of
metabolites was patented (Andrade, 2008). The initial inoculum
of the LV strain was obtained from a culture stored in glycerol
and cultivated as described above. When the culture was in log
phase (108 CFU mL−1, OD 0.09, λ = 590 nm) 100 μL of cell
suspension was inoculated in 1 L of nutrient broth (NB) plus
100mg L−1 CuCl2.2H2O and cultivated on a shaker for 10 days at
28◦C and 100 rpm. The culture was harvested and centrifuged at
9,000 rpm for 20 min at 4◦C. The metabolites were extracted ﬁve
times from the cell-free culture supernatant using two volumes of
dichloromethane each time (250 mL of supernatant and 500 mL
of dichloromethane) and was designated the dichloromethane
phase (DP). DP was puriﬁed by vacuum liquid chromatography
(VLC). VLC was carried out in a glass column (35 cm long with
diameter of 2 cm) ﬁlled with silica gel 60 (0.063–0.200 mm,
Merck) coupled to a vacuum pump with ∼150 mmHg−1. DP
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was fractionated using the following mobile phase (v/v): hexane
(F1), dichloromethane (F2), ethyl acetate (F3), methanol (F4),
methanol/water (1:1; F5) and water (F6). Forty milliliters of each
eluent was passed through the column 10 times, concentrated
in a rotary evaporator (Rotavapor R 215, Büchi) under reduced
pressure at 45◦C. The fractions were monitored by TLC and
antibiotic activity was identiﬁed by bioautography.
The F3 fraction (high level of antibiotic activity as shown in
the bioautography test) was again puriﬁed by VLC as described
above, except using the mobile phase (v/v): hexane (F3a),
hexane/dichloromethane [1:1, (F3b)], dichloromethane (F3c),
dichloromethane/ethyl acetate [1:1, (F3d)], ethyl acetate
(F3e), ethyl acetate/methanol [1:1, (F3f)], methanol (F3g),
methanol/water [1:1, (F3h)], and water (F3i). The fractions
were monitored by TLC and antibiotic activity was identiﬁed by
bioautography.
The F3d fraction (high level of antibiotic activity as shown in
the bioautography test and yield of 150 mg per liter of culture)
was again puriﬁed by ﬂash chromatography. F3d was mixed with
silica gel 60 (0.04–0.063 mm, Merck) to prepare the metabolite–
silica gel slurry, which was air-dried until complete evaporation
of the solvent at room temperature. The column (50 cm long
with diameter of 0.8 cm) was coupled to a low-pressure pump
and washed using a mobile phase (v/v) with diﬀerent proportions
of petroleum ether/dichloromethane/ethanol (68.5:30:1.5 and
50:40:10). Approximately 1 mL of the eluate was collected in
tubes and monitored by TLC. Similar fractions were combined
on the basis of TLC analysis and six combined fractions were
obtained (F3d.1 to F3d.6). Antibiotic activity was identiﬁed by
bioautography.
The F3d.3 fraction was again puriﬁed by ﬂash chromatography
as described above, except the mobile phase was: petroleum
ether/dichloromethane/ethanol (68.5:30:1.5), ethyl acetate and
ethyl acetate/ethanol (1:1). Fractions of approximately 1 mL
were collected in tubes and monitored by TLC. Similar
fractions were combined on the basis of TLC analysis, and
eight combined fractions were obtained (F3d.3.1 to F3d.3.8).
Antibiotic activity was identiﬁed by bioautography. The F3d.3.4
fraction (high level of antibiotic activity as shown in the
bioautography test) was again puriﬁed by ﬂash chromatography
as described above, except for the column size (20 cm long
with diameter of 0.6 cm). Two pure compounds were obtained
(F3d.3.4.2 and F3d.3.4.4), as summarized in a chart (Figure 1).
One milligram of pure compounds was dissolved (chloroform
and methanol, respectively) at room temperature and kept
for slow evaporation in a vial. All pure compounds were
then loaded on the high performance liquid chromatography
(HPLC) column and were further subjected to chemical
characterization.
TLC Analysis
Thin layer chromatography of the fractions was carried out on
silica gel plates (Merck 60 F254). The fractions were spotted
on plates and after drying, the chromatograms were developed
in dichloromethane/ethyl acetate/methanol (45:45:10) and/or
ethyl acetate/methanol (50:50). The spots were viewed under
ultraviolet light at 254 and 366 nm.
HPLC Analysis
The pure compounds as obtained above were further subjected
to HPLC using Agilent 1260 HPLC. The mobile phases used were
100%water (A) and 100% acetonitrile (B) at a ﬂow rate 1 mL/min
and injection volume was 100 μL at a column temperature of
25◦C (C18 Agilent HPLC column, 5 μm, 4.6 mm × 250 mm).
Eluate wasmonitored at diﬀerent wavelengths (250, 264, 290, 271,
316, and 366 nm).
Chemical Analysis
The pure compounds were dissolved in CDCl3 or CD3OD at
1,000 μg mL−1. Mass spectra were obtained with an ESI-MS
Quattro LCZ (Micromass, Manchester, UK). 1H and 13C nuclear
magnetic resonance spectra were recorded in solution using a
Bruker Avance III 400 MHz spectrometer. X-ray microanalysis
(EDS) was carried out using an FEI-Quanta 200 scanning
electron microscopy with an accelerating voltage of 25 kV.
Biological Analysis
Selection of Compounds with Antibiotic Activity by
Bioautography
The bioautography method (Rahalison et al., 1993) was used
to identify antibiotic activity. TLC plates were developed as
described above and placed in a Petri dish with 20 mL of melted
NA (45◦C) mixed with 1 mL of cell suspension of Xcc 306
(108 CFUmL−1), which was incubated for 48 h at 28◦C. The zone
of inhibition was used to identify the spots with compounds with
antibiotic activity.
Disk Diffusion Method
The disks were prepared with diﬀerent concentrations of semi-
puriﬁed fractions and puriﬁed compounds with antibiotic activity
(1,000 μg disk−1 with the DP extract and F3 fraction; 100 μg
disk−1 of F3d and F3d.3 fractions; 30 μg disk−1 of F3d.3.4
fraction and F3d.3.4.2, F3d.3.4.4 puriﬁed compounds), with
three replicates. The disks were placed on a Petri dish with
20 mL of NA previously inoculated with a cell suspension
of Xcc 306 (108 CFU mL−1) in the log phase. The solvent,
dichloromethane, was considered the negative control. Plates
were incubated for 48 h at 28◦C. The experiment was
repeated three times and the antibiotic eﬀect was determined
by measuring (mm) the inhibition halos formed around the
disks.
Minimum Inhibitory Concentration (MIC)
Xcc 306 was grown overnight in NB at 28◦C, and MIC was
determined in 96-well plates using twofold serial dilutions. The
concentrations tested ranged 2,500 to 4.88 μg mL−1 for DP
extract and F3 fraction, 400 to 0.78 μg mL−1 for F3d fraction
and 2 to 0.004 μg mL−1 for F3d.3.4.2 puriﬁed compound. The
inoculum usedwas 100μL of cell suspension of Xcc 306 (107 CFU
mL−1) per well. The growth control was a cell suspension of Xcc
306 in NB only, and the negative control was non-inoculated
NB. The antibiotic solution was mixed with NB to check for
sterility. Plates were incubated for 48 h at 28◦C. The optical
density was determined at 590 nm (BioMate 3). Afterward,
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FIGURE 1 | Flow chart of purification of Pseudomonas secondary metabolites.
cell viability was determined, where 20 μL of 1% 2, 3, 5-
triphenyltetrazolium chloride were added to all wells and the
plates incubated again at 28◦C for 20 min. Afterward, the wells
that showed a pink color indicated resistance (+), while no color
change indicated sensitivity (–). The experiment was repeated
three times.
Cytotoxicity Assay
The LLCMK2 cell line was grown in 96-well microplates
(Techno Plastic Products, Switzerland) containing RPMI
medium supplemented with 10% bovine serum, at a density of
2.5 × 104 cells/well for 24 h in 5% CO2, 37◦C. At conﬂuence,
non-adherent cells were removed by washing with sterile 0.15 M
phosphate-buﬀered saline pH 7.2 (PBS). Afterward, twofold
serial dilutions of F3d with antibiotic activity were made (2000
to 1 μg mL−1) and added to each well containing the cells.
The plates were incubated for 72 h at 37◦C in 5% CO2. Cell
viability was determined by the dimethylthiazol-diphenyl-
tetrazolium-bromide [MTT – (Sigma Chemical Co, USA)]
method according to the manufacturer’s recommendations.
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Wells containing medium alone or medium plus 1% DMSO
served as growth and sterility controls. The concentration of
F3d needed to reduce cell viability up to 50% by regression
analysis corresponded to the 50% cytotoxic concentration
(CC50).
Foliar Application to Control Citrus Canker Under
Greenhouse Conditions
Plants of C. sinensis cv. Valence were grown in 3-L pots with
non-sterile rhodic ferralsol soil (FAO, 1994) in a greenhouse
(28◦C/22◦C and 10 h/14 h day/night period, 80% relative
humidity). Every 15 days, 150 mL of Hewitt’s solution for
non-legume plants (Hewitt, 1966) were added, and plants were
watered with tap water when needed. The experiments were
carried out in a completely randomized block design using
two regimens, preventive and curative, and three doses of F3d
according to the MIC (D1 = 1 μg mL−1; D2 = 10 μg mL−1;
and D3 = 100 μg mL−1) with ﬁve replicates of each treatment
(2 × 3 × 5). Positive control plants were sprayed with Xcc
306 cell suspension and negative control plants with distilled
water. Xcc 306 infection was carried out with plants kept in a
humid chamber, where plants were covered with 150 L black
plastic bags for 24 h at 30◦C to maintain high humidity and
stoma opening, before and after spraying bacterial suspension or
antibiotic solution. Two spray times were used to test for curative
or preventive eﬀect against citrus canker. In the preventive
regimen, 8 mL of F3d fraction were sprayed per plant 24 h
before spraying with 8 mL of Xcc 306 (108 CFU mL−1). In the
curative regimen, plants were sprayed ﬁrst with Xcc 306 and
F3d 24 h later. Negative controls were sprayed with 8 mL of
distilled water (the solvent used to dilute F3d). The number of
lesions was determined after 21 days of last spraying. Considering
the high lesion formation and homogeneity in control plants,
the number of lesions in an area was determined with a
stereomicroscope (40×) and accordingly multiplied to obtain
the number for the whole leaf area. Data were analyzed with
SigmaPlot software and quadratic regression, where p ≤ 0.01 was
considered signiﬁcant.
Ultrastructural Evaluation
Samples of orange leaf (6 mm in diameter) were collected
during the plant experiment under greenhouse conditions
(24 and 120 h) in both treatment regimens (curative and
preventive) at a dose of 10 μg mL−1. For SEM analysis,
samples collected at 24 h were ﬁxed by immersion in
2.5% glutaraldehyde, 2% paraformaldehyde in 0.1 M sodium
cacodylate buﬀer, post-ﬁxed in 1% OsO4, and dehydrated in
an ethanol series (70, 80, 90, and 100%). Samples were critical-
point dried with CO2 (BALTEC CPD 030 Critical Point Dryer),
coated with gold (BALTEC SDC 050 Sputter Coater) and
observed under a scanning electron microscope (FEI Quanta
200). For transmission electron microscopy (TEM) analysis,
samples collected at 120 h were ﬁxed and dehydrated as
described above and were embedded and blocked in Araldite R©
resin. Ultrathin sections (60–70 nm) were stained with uranyl
acetate and lead citrate and observed under a TEM (FEI
Tecnai 12).
RESULTS
Purification, Crystallization, and
Characterization of Purified Compounds
Two major metabolites were isolated from F3d fraction, and
crystals were analyzed after complete evaporation. The ﬁrst
pure compound (F3d.3.4.2) showed a single peak at UV
absorption of 271 nm and high antibiotic activity (Supplementary
Figure S1). F3d.3.4.2 appeared as low-quality dark-green crystals
after evaporation. It was completely soluble in DMSO and
CDCl3. The molecular structure has not yet been completely
determined. On the basis of the spectral data, the bioactive
compound was determined to be a natural organocopper
antibiotic compound (OAC; Supplementary Figures S2–S4). The
second one (F3d.3.4.4) appeared as high-quality ﬁne yellow
crystals. It was completely soluble in DMSO and CD3OD. ESI-
MS and NMR analysis of this bioactive compound was close
to that proposed by Naik and Sakthivel (2006), phenazine-1-
carboxamide (PCN), with the molecular formula C13H9N3O
(Supplementary Figures S5–S8).
Evaluation of In vitro Antibiotic Activity
Whole puriﬁcation steps of the DP extract were monitored
by bioautography until pure compounds were obtained, and
only the fractions F3, F3d, F3d.3, F3d.3.4, and OAC (F3d.3.4.2)
showed signiﬁcant antimicrobial activity. The other fractions and
PCN did not show any antibiotic activity under the experimental
conditions used in this study.
As the puriﬁcation process proceeded, the antibiotic activity
against Xcc 306 increased, where DP extract showed a lower
inhibitory eﬀect in the disc diﬀusion assay (21.5 mm at
1,000 μg disk−1) when compared with more puriﬁed fractions:
F3 (26.5 mm at 1,000 μg), F3d (32 mm at 100 μg), F3d.3 (42 mm
at 100 μg), and F3d.3.4 (39 mm at 30 μg). The activity increased
further when testing the OAC, which showed an inhibition halo
of 67 mm at 30 μg mL−1 against Xcc 306 (Table 1 and Figure 2).
The same results were observed in the MIC assay against Xcc
306, where DP, F3, and F3d were 78.12, 19.53, and 6.25 μg mL−1,
respectively. OAC showed a high level of antibiotic activity with
a MIC of 0.12 μg mL−1 (Table 2).
F3d was chosen to use in the greenhouse experiments for
many reasons, namely good availability, strong antibiotic activity
and because it was mostly composed of OAC (30%), where it was
known that OAC was the only component with high antibiotic
activity.
Cytotoxicity Assay
It was not possible to determine the 50% cytotoxic concentration
of F3d to LLC-MK2 cells, since with the highest concentration
tested (2000 μg mL−1), around 84% against the mammalian cells
were viable, according to the MTT assay.
Foliar Application to Control Citrus
Canker Under Greenhouse Conditions
The preventive treatment showed a high correlation between
dose and lesion number (r2 = 0.95; p < 0.01). All doses of
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TABLE 1 | Antibiotic activity against Xcc 306 by disk diffusion technique of fractions and pure compound obtained from purification of extract containing
secondary metabolites produced by Pseudomonas aeruginosa LV strain.
Concentration (µg disk−1) Fractions Purified compounds
FD F3 F3d F3d.3 F3d.3.4 F3d.3.4.2 (OAC) F3d.3.4.4(PCN)
Inhibition zone diameter (mm)
1,000 21.5 ± 1 26.5 ± 1 ∗ ∗ ∗ ∗ ∗
100 ∗ ∗ 32 ± 0.5 42 ± 1 ∗ ∗ ∗
30 ∗ ∗ ∗ ∗ 39 ± 0.5 67 ± 0.5 −
NC − − − − − − −
Test substances were previously selected by bioautography. Solvent was used as the negative control. The data represent the mean ± standard deviation of three
replicates. Negative control (NC); no tested (∗ ); absence of zone of inhibition (–); organocopper antibiotic compound (OAC); phenazine-1-carboxamide (PCN).
FIGURE 2 | Effect of Pseudomonas secondary metabolites on the growth of Xcc 306.
F3d decreased lesion number when compared with untreated
plants: 1 μg mL−1 = 90%, 10 μg mL−1 = 93%, and 100 μg
mL−1 = 97% (Figure 3A). The curative treatment showed the
same correlation (r2 = 0.97; p < 0.01), but lesion number was
higher when compared with the preventive treatment, two times
at 1 μg mL−1 and three and half times at 10 and 100 μg mL−1
(Figure 3B).
Ultrastructural Evaluation
In SEM, a large number of Xcc 306 cells were observed on
the leaf surface and they appeared intact and embedded
TABLE 2 | Determination of minimum inhibitory concentration of fractions
and pure compounds obtained from secondary metabolites produced by
Pseudomonas aeruginosa LV strain, against Xcc 306.
Sample MIC (µg mL−1)
DP 78.12
F3 19.53
F3d 6.25
F3d.3.4.2 (OAC) 0.12
NC –
Negative control (NC); dichloromethane phase (DP); no antibiotic activity (–);
organocopper antibiotic compound (OAC).
in amorphous extracellular polysaccharides (EPS) 24 h
after inoculation (Figures 4A,B). With preventive
(Figures 4C,D) and curative (Figures 4E,F) treatments,
the number of bacteria decreased, and morphological
changes in bacterial shape and EPS were observed
after 24 h.
In TEM, the negative control (non-inoculated leaf) showed
no change in the mesophyll, which appeared to have intact cell
walls, with the substomatal chamber having an electron-lucid
appearance, after 120 h (Figure 5A, inset). In the positive control
(infected and untreated plant), viable bacteria were frequently
observed in the intercellular spaces and substomatal chamber
of the leaf, and plant cell organelles appeared damaged. The
intracellular space and the substomatal chamber were full of
EPS evidenced by its electron-dense appearance (Figure 5B,
inset).
After 120 h in the preventive treatment, there were few
bacterial cells in the leaf mesophyll, altered bacterial cell
morphology, and diﬀerences in electron-dense aspect of the
substomatal chamber (suggesting absence of EPS), and the
mesophyll cells were unaltered, while the bacterial cells (Xcc
306) appeared lysed (Figures 5C–E). After 120 h in the curative
treatment, the same eﬀects were found in orange leaves when
compared with the preventive treatment, including the eﬀect on
bacterial cells (Figures 5F–H).
Frontiers in Microbiology | www.frontiersin.org 6 February 2016 | Volume 7 | Article 113
de Oliveira et al. Organocopper Antibiotic Compound Against Xanthomonas citri
FIGURE 3 | Determination of dose–effect relation for F3d semi-purified fraction against the number of lesions of citrus canker caused by Xcc 306
strain in leaf of C. sinensis cv. Valence, 21 days after application (n = 50). (0 = Xcc 306 suspension not treated; 1 = 1 μg mL−1; 2 = 10 μg mL−1;
3 = 100 μg mL−1. (A) Preventive treatment. (B) Curative treatment.
DISCUSSION
Previous studies have shown the antibiotic eﬀect of Pseudomonas
secondary metabolites against various bacterial species (de
Oliveira et al., 2011; Lopes et al., 2012; Cardozo et al., 2013;
Spago et al., 2014). In the present study, we evaluated the
eﬀect of F3d, a semi-puriﬁed fraction, on plants infected
by Xcc 306, evaluating antibiotic eﬀectiveness in the initial
infection process on the leaf and the antibiotic control of Xcc
306 infecting the mesophyll tissue inside the lesions, and we
determined the active pure compound present in the F3d fraction
(30% OAC). The product used in this study, showed about
90% reduction in citrus canker lesion formation in orange
plants at a concentration of 1 μg mL−1, a concentration
about 200 times lower than that for the recommended
commercial copper-based compound, and more active than
other products tested for control of citrus canker (Silva et al.,
2013).
The observed antibiotic eﬀect of F3d on citrus canker diﬀered
when comparing preventive and curative regimens, where the
preventive was more eﬀective in the control of lesion formation
and number of bacteria on leaf surface in the mesophyll inside the
lesion.
The diﬀerences observed between preventive and curative
regimens suggested that when the plants were inoculated with
Xcc 306 after F3d application (preventive), F3d reduced the
bacterial population during the ﬁrst hours, which was also
observed in in vitro experiments. In this way, the substantial
control of Xcc 306 observed in a preventive treatment was likely
related to mechanisms other than antibiotic activity such as SAR.
The preventive eﬀect was also observed in other studies with
diﬀerent species of Xanthomonas and host plants (Lopes et al.,
2012; Spago et al., 2014; Vasconcellos et al., 2014). Phenazine
can inﬂuence growth and induce SAR in plants (Pierson and
Pierson, 2010), and is produced by many bacterial species.
Diﬀerent phenazines are produced by the same bacterial species
but in diﬀerent proportions and with diﬀerent activities (Pierson
and Pierson, 2010). The PCN isolated in this study did not
show antibiotic activity. On the other hand, PCN bioactivity
in citrus canker control could be related to the induction of
resistance mechanisms, which needs to be elucidated in further
studies.
By electron microscopy, it was possible to observe the
bacteriolytic activity of F3d in treated plants compared with
untreated plants. The infection of orange leaves by Xcc 306 in
untreated plants caused changes in the mesophyll cells, where
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FIGURE 4 | Scanning electron micrographs of orange leaf (C. sinensis cv. Valence) inoculated with 108 CFU mL−1 Xcc 306. (A) Control (not treated with
F3d) 24 h after inoculation; large number of Xcc 306 present on leaf surface with intact appearance. (B) Higher magnification of control; there is a thick layer of
extracellular polysaccharides (EPS) on the leaf surface. (C) Preventive treatment 24 h after F3d application, showing a decreased number of bacteria and presence
of non-viable Xcc 306 and altered EPS. (D) Higher magnification of preventive treatment; observed morphological changes in bacterial shape and EPS. (E) Curative
treatment 24 h after F3d application, showing a decreased number of bacteria and morphological changes in bacterial shape and EPS. (F) Higher magnification of
curative treatment; observed morphological changes in bacterial shape and EPS absence. (VB, viable cell; NB, non-viable cells; Arrowhead = Xcc 306 embedded in
amorphous EPS; Arrow = changed in the configuration of EPS).
ﬁbrillar material was found in the cell walls leaking into the
intercellular space. Also, viable bacterial cells were frequently
observed in the intercellular spaces, and the substomatal chamber
was ﬁlled with homogeneous EPS. On the other hand, treated
plants showed non-viable bacterial cells in the mesophyll (lysed
or disintegrated bacterial cells), and mesophyll morphology and
cell walls remained unaltered, suggesting that F3d acted inside
the leaf and did not have a phytotoxic eﬀect at all concentrations
tested.
Transmission electron microscopy showed the absence of
EPS in the intercellular space in infected C. sinensis Valence
leaves treated with F3d. This result corroborated the ﬁndings of
de Oliveira et al. (2011), who demonstrated that Pseudomonas
crude secondarymetabolites not only possessed antibiotic activity
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FIGURE 5 | Transmission electron micrographs of orange leaf (C. sinensis cv. Valence) inoculated with 108 CFU mL−1 Xcc 306. (A) Leaf of
non-inoculated plant, showing complete absence of Xcc 306 cells and EPS in the intercellular space of mesophyll cells. Inset shows an intact cell wall at higher
magnification. (B) Control not treated with F3d 120 h after inoculation, showing the intercellular space colonized with Xcc 306 and EPS evidenced by the
electron-dense appearance. Inset shows viable bacterial cells present in the intercellular space in contact with host cell wall and disruption process at higher
magnification. (C) The 120 h after inoculation in the preventive treatment; non-viable Xcc 306 cells are shown at the entrance of outer stomatal chamber and
substomatal chamber. (D) After 120 h of preventive treatment, few bacterial cells are seen in the leaf mesophyll, with altered bacterial cell morphology and different
electron-dense appearance in intercellular space (suggesting absence of EPS). (E) After 120 h of inoculation in the preventive treatment, higher magnification of
Figure 4D, showing the presence of non-viable Xcc 306 cells in the substomatal chamber. (F) After 120 h in the curative treatment, the same effects are seen when
compared with preventive treatment on orange leaves, including the effect on bacterial cells. (G) Mesophyll cells are unaltered and bacterial cells (Xcc 306) appear
lysed, with different electron-dense appearance in intercellular space (suggesting absence of EPS). (H) Presence of non-viable Xcc 306 cells in the intact mesophyll
cell and absence of EPS at higher magnification of Figure 4F. (CW, host cell wall; IS, intercellular space; SC, substomatal chamber; VB, viable cell; V, vesicle;
arrowhead, non-viable Xcc 306 cell).
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but also altered bacterial cell morphology and reduced the
presence of EPS in an in vitro study. Considering these results
and also the ﬁnding of 97% reduction in the number of lesions
in treated plants, F3d had two activities: it killed the bacteria and
aﬀected the formation of EPS.
The function of EPS in Xanthomonas species is controversial,
and many authors have reported that EPS production is
associated with the virulence level of many Xanthomonas species
(Katzen et al., 1998; Dharmapuri and Sonti, 1999; Kemp et al.,
2004). On the other hand, authors consider that EPS does
not play an essential role in citrus canker in the initial stages
of infection but facilitates the maintenance of bacteria in the
host plant, possibly improving the eﬃciency of colonization
in deep tissue of the leaf (Dunger et al., 2007). According to
Rigano et al. (2007), in X. axonopodis pv. citri, xanthan is
essential for the formation of microcolonies and the subsequent
development of more complex structures, in which bacteria
are tightly packed in hexagonal arrays separated by water-ﬁlled
channels. Such complex structures are found both in vitro and
in planta. In addition, the same authors reported in their studies
that the presence of plant-associated bioﬁlms was correlated
with X. axonopodis pv. citri pathogenicity, which was markedly
attenuated by the disruption of a single gene involved in the
biosynthesis of EPS.
The present study showed that semi-puriﬁed secondary
metabolites (F3d) had strong antibiotic activity without
phytotoxicity to orange plants, and that activity persisted for
many weeks on the phylloplane and inside the leaf, reducing the
inoculum potential outside and inside the citrus canker lesions.
F3d has great potential in the near future for use in the ﬁeld to
control citrus canker disease, but more ﬁeld studies are needed
ﬁrst.
AUTHOR CONTRIBUTIONS
All authors listed, have made substantial, direct and
intellectual contribution to the work, and approved it for
publication.
FUNDING
We thank the Brazilian National Council of Scientiﬁc and
Technological Development (CNPq) (143195/2008-5).
ACKNOWLEDGMENTS
The authors are grateful to the Brazilian National Council
of Scientiﬁc and Technological Development (CNPq) for
making this study possible by awarding PIBIC, MSc., Ph.D.,
and Productivity in Research grants. The authors would also
like to thank the Nuclear Magnetic Resonance Laboratory –
RMN UEL/FINEP for help with the NMR experiments and
Laboratory for Electron Microscopy and Microanalysis –
LMEM UEL/FINEP for help with the electron microscopy
experiments. Dr. A. Leyva helped with English editing of the
manuscript.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: http://journal.frontiersin.org/article/10.3389/fmicb.
2016.00113
REFERENCES
Andrade, G. (2008). Process of Production, Puriﬁcation and Obtation of
Substances with Antibiotic Activity to Control Diseases Caused by Bacteria in
Plants. BR Patent No PI0803350-1A. Brazil Patent Application. Available at:
www.inpi.gov.br
Balogh, B., Canteros, B. I., Stall, K. E., and Jones, J. B. (2008). Control of citrus
canker and citrus bacterial spot with bacteriophages. Plant Dis. 92, 1048–1052.
doi: 10.1094/PDIS-92-7-1048
Belasque, J. R. J., and Behlau, F. (2011). “Current status of citrus canker control
in São Paulo state, Brazil: a new chapter in a 50-year book?,” in Workshop on
Xanthomonas citri/Citrus Canker, eds H. Ferreira and J. Jr. Belasque (Ribeirão
Preto: UNESP/Fundecitrus), 14–16.
Cardozo, V. F., de Oliveira, A. G., Nishio, E. K., Perugini, M. R. E., Andrade,
C. G. T. J., Silveira, W. D., et al. (2013). Antibacterial activity of extracellular
compounds produced by a Pseudomonas strain against methicillin-resistant
Staphylococcus aureus (MRSA) strains. Ann. Clin.Microbiol. Antimicrob. 12, 12.
doi: 10.1186/1476-0711-12-12
Chagas, M. C. M., Parra, J. R. P., Namekata, T., Hartung, J. S., and Yamamoto,
P. T. (2001). Phyllocnistis citrella stainton (Lepidoptera: Gracillariidae) and its
relationship with the citrus canker bacterium Xanthomonas axonopodis pv.
citri in Brazil. Neotrop. Entomol. 30, 55–59. doi: 10.1590/S1519-566X20010001
00009
Chan, J. W. Y. F., and Goodwin, P. H. (1999). The molecular genetics of virulence
of Xanthomonas campestris. Biotechnol. Adv. 17, 489–508. doi: 10.1016/S0734-
9750(99)00025-7
da Silva, A. C. R., Ferro, J. A., Reinach, F. C., Farah, C. S., Furlan, L. R.,
Quaggio, R. B., et al. (2002). Comparison of the genomes of two Xanthomonas
pathogens with diﬀering host speciﬁcities. Nature 417, 459–463. doi: 10.1038/4
17459a
de Oliveira, A. G., Murate, L. S., Spago, F. R., Lopes, L. D., Beranger, J. P. D.,
San Martin, J. A. B., et al. (2011). Evaluation of the antibiotic activity
of extracellular compounds produced by the Pseudomonas strain against
the Xanthomonas citri pv. citri 306 strain. Biol. Control 56, 125–131. doi:
10.1016/j.biocontrol.2010.10.008
Dharmapuri, S., and Sonti, R. V. (1999). A transposon insertion in the gumG
homologue of Xanthomonas oryzae pv. oryzae causes loss of extracellular
polysaccharide production and virulence. FEMSMicrobiol. Lett. 179, 53–59. doi:
10.1016/S0378-1097(99)00367-5
Dowling, D. N., and O’Gara, F. (1994). Metabolites of Pseudomonas involved in the
biocontrol of plant disease. Trends Biotechnol. 12, 133–141. doi: 10.1016/0167-
7799(94)90091-4
Dunger, G., Relling, V., Tondo, M., Barreras, M., Ielpi, L., Orellano, E., et al.
(2007). Xanthan is not essential for pathogenicity in citrus canker but
contributes to Xanthomonas epiphytic survival. Arch. Microbiol. 188, 127–135.
doi: 10.1007/s00203-007-0227-8
FAO (1994). Soil Map of the World. Revised Legend. Reprinted with Corrections.
World Soil Resources Report 60. Rome: FAO.
Fu, X. Z., Chen, C. W., Wang, Y., Liu, J. H., and Moriguchi, T. (2011). Ectopic
expression ofMdSPDS1 in sweet orange (Citrus sinensisOsbeck) reduces canker
susceptibility: involvement of H2O2 production and transcriptional alteration.
BMC Plant Biol. 11:55. doi: 10.1186/1471-2229-11-55
Frontiers in Microbiology | www.frontiersin.org 10 February 2016 | Volume 7 | Article 113
de Oliveira et al. Organocopper Antibiotic Compound Against Xanthomonas citri
Fuller, A. T., Mellows, G., Woolford, M., Banks, G. T., Barrow, K. D., and
Chain, E. B. (1971). Pseudomonic acid: an antibiotic produced by Pseudomonas
ﬂuorescens. Nature 234, 416–417. doi: 10.1038/234416a0
Gabriel, D. W., Kingsley, M. T., Hunter, J. E., and Gottwald, T. (1989).
Reinstatement of Xanthomonas citri (ex Hasse) and X. phaseoli (ex Smith) to
species and reclassiﬁcation of all X. campestris pv. citri strains†. Int. J. Syst. Evol.
Microbiol. 39, 14–22. doi: 10.1099/00207713-39-1-14
Góis, C. M., Lopes-Santos, L., Oliveira, J. P. B., de Oliveira, A. G., Spago, F.,
and Andrade, G. (2013). The control of Lactobacillus sp. by extracellular
compound produced by Pseudomonas aeruginosa in the fermentation process
of fuel ethanol industry in Brazil. J. Sustain. Bioenergy Syst. 3, 194–201. doi:
10.4236/jsbs.2013.33027
Gottwald, T. R., and Graham, J. H. (2000). “Canker,” in Compendium of Plant
Disease Series, eds L. W. Timmer, S. M. Garnsey, and J. H. Graham (St. Paul
Minnesota: American Phytopathological Society Press Inc.).
Gottwald, T. R., Graham, J. H., and Schubert, T. S. (2002). Citrus canker: the
pathogen and its impact. Plant Health Prog. doi: 10.1094/PHP-2002-0812-
01-RV
Graham, J. H., and Leite, R. P. (2004). Lack of control of citrus canker
by induced systemic resistance compounds. Plant Dis. 88, 745–750. doi:
10.1094/PDIS.2004.88.7.745
Graham, J. H., and Myers,M. (2009). Soil drenches of imidacloprid, thiamethoxam
and acibenzolar-S-methyl for induction of SAR to control citrus canker in
young citrus trees. Phytopathology 99, S46.
Gross, H., and Loper, J. E. (2009). Genomics of secondary metabolite production
by Pseudomonas spp. Nat. Prod. Rep. 26, 1408–1446. doi: 10.1039/B817075B
Haas, D., and Défago, G. (2005). Biological control of soil-borne pathogens
by ﬂuorescent Pseudomonads. Nat. Rev. Microbiol. 3, 307–319. doi:
10.1038/nrmicro1129
Haas, D., and Keel, C. (2003). Regulation of antibiotic production
in root-colonizing Pseudomonas spp. and relevance for biological
control of plant disease. Annu. Rev. Phytopathol. 41, 117–153. doi:
10.1146/annurev.phyto.41.052002.095656
Hewitt, E. J. (1966). Sand and Water Culture Methods Used in the Study of Plant
Nutrition, 2nd Edn. Farnham Royal: Commonwealth Agricultural Bureaux,
547. doi: 10.1017/S0014479700021852
Katzen, F., Ferreiro, D. U., Oddo, C. G., Ielmini, M. V., Becker, A., Pühler, A.,
et al. (1998). Xanthomonas campestris pv. campestris gum mutants: eﬀects on
xanthan biosynthesis and plant virulence. J. Bacteriol. 180, 1607–1617.
Kemp, B. P., Horne, J., Bryant, A., and Cooper, R. M. (2004). Xanthomonas
axonopodis pv. manihotis gumD gene is essential for EPS production and
pathogenicity and enhances epiphytic survival on cassava (Manihot esculenta).
Physiol. Mol. Plant Pathol. 64, 209–218. doi: 10.1016/j.pmpp.2004.08.007
Leisinger, T., and Margraﬀ, R. (1979). Secondary metabolites of the ﬂuorescent
pseudomonads.Microbiol. Rev. 43, 422–442.
Ligon, J. M., Hill, D. S., Hammer, P. E., Torkewitz, N. R., Hofmann, D.,
Kempf, H. J., et al. (2000). Natural products with antifungal activity
from Pseudomonas biocontrol bacteria. Pest Manag. Sci. 56, 688–695. doi:
10.1002/1526-4998(200008)56:8<688::AID-PS186>3.0.CO;2-V
Lopes, L. P., de Oliveira, A. G., Beranger, J. P. O., Gois, C. G., Vasconcellos,
F. C. S., San Martin, J. A. B., et al. (2012). Activity of extracellular compounds
of Pseudomonas sp. against Xanthomonas axonopodis in vitro and bacterial
leaf blight in eucalyptus. Trop. Plant Pathol. 37, 233–238. doi: 10.1590/S1982-
56762012000400001
Miller, A. M., Barreto, T. P., Silva, M. R. L., and Leite, R. P. Jr. (2011). “Control of
citrus canker mediated by neonicotinoids in combination with acibenzolar-S-
methyl,” inWorkshop on Xanthomonas citri/Citrus Canker, eds H. Ferreira and
J. Belasque Jr. (Ribeirão Preto: UNESP/Fundecitrus), 50–52.
Murate, L., de Oliveira, A. G., Higashi, A., Barazetti, A., Simionato, A. S., Silva, C.,
et al. (2015). Activity of secondary bacterial metabolites in the control of citrus
canker. Agric. Sci. 6, 295–303. doi: 10.4236/as.2015.63030
Naik, P. R., and Sakthivel, N. (2006). Functional characterization of a
novel hydrocarbonoclastic Pseudomonas sp. strain PUP6 with plant-growth-
promoting traits and antifungal potential. Res. Microbiol. 157, 538–546. doi:
10.1016/j.resmic.2005.11.009
Neves, M. F., Trombin, V. G., Milan, P., Lopes, F. F., Cressoni, F., and Kalaki, R.
(2010). O Retrato da Citricultura Brasileira. Ribeirão Preto: CitrusBR. Alto da
Boa Vista: Markestrat, 137.
Paulsen, I. T., Press, C. M., Ravel, J., Kobayashi, D. Y., Myers, G. S., Mavrodi,
D. V., et al. (2005). Complete genome sequence of the plant commensal
Pseudomonas ﬂuorescens Pf-5. Nat. Biotechnol. 23, 873–878. doi: 10.1038/
nbt1110
Pierson, L. S., and Pierson, E. A. (2010). Metabolism and function of phenazines
in bacteria: impacts on the behavior of bacteria in the environment and
biotechnological processes. Appl. Microbiol. Biotechnol. 86, 1659–1670. doi:
10.1007/s00253-010-2509-3
Raaijmakers, J. M., de Bruijn, I., and de Kock, M. J. (2006). Cyclic
lipopeptide production by plant-associated Pseudomonas spp: diversity,
activity, biosynthesis, and regulation.Mol. Plant Microbe Interact. 19, 699–710.
doi: 10.1094/MPMI-19-0699
Raaijmakers, J., Vlami, M., and de Souza, J. (2002). Antibiotic production
by bacterial biocontrol agents. Antonie Van Leeuwenhoek 81, 537–547. doi:
10.1023/A:1020501420831
Raaijmakers, J. M., Weller, D. M., and Thomashow, L. S. (1997). Frequency
of antibiotic-producing Pseudomonas spp. in natural environments. Appl.
Environ. Microbiol. 63, 881–887. PMC1389120,
Rahalison, L., Hamburger, M., Hostettmann, K., Monod, M., Frenk, E.,
Gupta, M., et al. (1993). Screening for antifungal activity of
Panamanian plants. Pharm. Biol. 31, 68–76. doi: 10.3109/138802093090
82921
Rampazo, L. G. L. (2004). Evaluation of the Eﬀect of Biological Agents and their
Products into the Incidence of Citrus Canker Lesions. Master thesis, Universidade
Estadual de Londrina, Londrina.
Rigano, L. A., Siciliano, F., Enrique, R., Sendin, L., Filippone, P., Torres, P. S.,
et al. (2007). Bioﬁlm formation, epiphytic ﬁtness, and canker development in
Xanthomonas axonopodis pv. citri.Mol. Plant Microbe Interact. 20, 1222–1230.
doi: 10.1094/MPMI-20-10-1222
Schaad, N. W., Postnikova, E., Lacy, G., Sechler, A., Agarkova, I., Stromberg,
P. E., et al. (2006). Emended classiﬁcation of xanthomonad pathogens
on citrus. Syst. Appl. Microbiol. 29, 690–695. doi: 10.1016/j.syapm.2006.
08.001
Schaad, N. W., Postnikova, E., Lacy, G. H., Sechler, A., Agarkova, I., Stromberg,
P. E., et al. (2005). Reclassiﬁcation of Xanthomonas campestris pv. citri (ex
Hasse 1915) Dye 1978 forms A, B/C/D, and E as X. smithii subsp. citri
(ex Hasse) sp. nov. nom. rev. comb. nov X. fuscans subsp. aurantifolii
(ex Gabriel 1989) sp. nov. nom. rev. comb. Nov. and X. alfalfae subsp.
citrumelo (ex Riker and Jones) Gabriel et al., 1989 sp. nov. nom. rev.
comb. nov.; X. campestris pv. malvacearum (ex Smith 1901) Dye 1978
as X. smithii subsp. smithii nov. comb. nov. nom. nov.; X. campestris
pv. alfalfae (ex Riker and Jones, 1935) Dye 1978 as X. alfalfae subsp.
alfalfae (ex Riker et al. 1935) sp. nov. nom. rev.; and “var. fuscans” of
X. campestris pv. phaseoli (ex Smith, 1987) Dye 1978 as X. fuscans subsp.
fuscans sp. nov. Syst. Appl. Microbiol. 28, 494–518. doi: 10.1016/j.syapm.2005.
03.017
Schubert, T. S., and Sun, X. (1996). Bacterial Citrus Canker. Plant Pathology
Circular No. 377, Florida Department of Agriculture & Consumer Services,
5th Revision January 2003. Avaialable at: http://www.freshfromflorida.com/pi/
enpp/pathology/pathcirc/ppcirc377-rev5.pdf
Silva, I. C., Regasini, L. O., Petrônio, M. S., Silva, D. H. S., Bolzani, V. S.,
Belasque, J., et al. (2013). Antibacterial activity of alkyl gallates against
Xanthomonas citri subsp. citri. J. Bacteriol. 195, 85–94. doi: 10.1128/JB.
01442-12
Spago, F. R., Mauro, C. S. I., de Oliveira, A. G., Beranger, J. P. O., Cely,
M. V. T., Stanganelli, M. M., et al. (2014). Pseudomonas aeruginosa produces
secondary metabolites that have biological activity against plant pathogenic
Xanthomonas species. Crop Prot. 62, 46–54. doi: 10.1016/j.cropro.2014.
04.011
USDA (2015). Fresh Fruit Makes Up a Growing Share of U.S. Fruit
Availability. Available at: http://www.ers.usda.gov/amber-waves/2015-may/
fresh-fruit-makes-up-a-growing-share-of-us-fruit-availability.aspx#.VnRoPP
krKUm (accessed December 18, 2015)
Vasconcellos, F. C. S., de Oliveira, A. G., Lopes-Santos, L., Beranger,
J. P. O., Cely, M. V. T., Simionato, A. S., et al. (2014). Evaluation of
antibiotic activity produced by Pseudomonas aeruginosa LV strain against
Xanthomonas arboricola pv. pruni. Agric. Sci. 05, 71–76. doi: 10.4236/as.2014.
51008
Frontiers in Microbiology | www.frontiersin.org 11 February 2016 | Volume 7 | Article 113
de Oliveira et al. Organocopper Antibiotic Compound Against Xanthomonas citri
Yang, L., Hu, C., Li, N., Zhang, J., Yan, J., and Deng, Z. (2011). Transformation of
sweet orange [Citrus sinensis (L.) Osbeck] with pthA-nls for acquiring resistance
to citrus canker disease. Plant Mol. Biol. 75, 11–23. doi: 10.1007/s11103-010-
9699-z
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or ﬁnancial relationships that could
be construed as a potential conﬂict of interest.
Copyright © 2016 de Oliveira, Spago, Simionato, Navarro, da Silva, Barazetti,
Cely, Tischer, San Martin, de Jesus Andrade, Novello, Mello and Andrade. This
is an open-access article distributed under the terms of the Creative Commons
Attribution License (CC BY). The use, distribution or reproduction in other forums
is permitted, provided the original author(s) or licensor are credited and that the
original publication in this journal is cited, in accordance with accepted academic
practice. No use, distribution or reproduction is permitted which does not comply
with these terms.
Frontiers in Microbiology | www.frontiersin.org 12 February 2016 | Volume 7 | Article 113
